About iBio, Inc.
https://www.ibioinc.comiBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing.
CEO
Martin B. Brenner
Compensation Summary
(Year 2025)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2023-11-29 | Reverse | 1:20 |
| 2022-10-10 | Reverse | 1:25 |
ETFs Holding This Stock
Summary
Showing Top 2 of 12
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
LYNX1 CAPITAL MANAGEMENT LP
Shares:1.06M
Value:$2.63M
IKARIAN CAPITAL, LLC
Shares:617.33K
Value:$1.54M
AMERIPRISE FINANCIAL INC
Shares:482.3K
Value:$1.2M
Summary
Showing Top 3 of 39
About iBio, Inc.
https://www.ibioinc.comiBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q1-2026 | $100K ▼ | $5.76M ▲ | $-5.72M ▼ | -5.72K% ▼ | $-0.11 ▲ | $-5.39M ▼ |
| Q4-2025 | $200K ▲ | $5.4M ▲ | $-5.16M ▼ | -2.58K% ▼ | $-0.31 ▲ | $-4.83M ▼ |
| Q3-2025 | $0 ▼ | $4.88M ▲ | $-4.86M ▼ | 0% ▲ | $-0.49 ▼ | $-4.53M ▼ |
| Q2-2025 | $200K ▲ | $4.62M ▲ | $-4.36M ▼ | -2.18K% ▼ | $-0.48 ▼ | $-4.03M ▼ |
| Q1-2025 | $0 | $4.11M | $-3.99M | 0% | $-0.46 | $-3.65M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q1-2026 | $49.57M ▲ | $64.16M ▲ | $8.12M ▼ | $56.04M ▲ |
| Q4-2025 | $8.58M ▲ | $23.18M ▲ | $8.3M ▲ | $14.88M ▲ |
| Q3-2025 | $4.96M ▼ | $19.1M ▼ | $7.72M ▼ | $11.38M ▼ |
| Q2-2025 | $7.01M ▼ | $21.7M ▼ | $7.8M ▲ | $13.89M ▼ |
| Q1-2025 | $11.04M | $24.52M | $6.76M | $17.75M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q1-2026 | $-5.72M ▼ | $-5.67M ▼ | $-21.49M ▼ | $46.7M ▲ | $19.53M ▲ | $-5.7M ▼ |
| Q4-2025 | $-5.16M ▼ | $-4.62M ▼ | $45K ▲ | $8.18M ▲ | $3.61M ▲ | $-4.62M ▼ |
| Q3-2025 | $-4.86M ▼ | $-3.1M ▲ | $-14K ▼ | $1.06M ▲ | $-2.06M ▲ | $-3.12M ▲ |
| Q2-2025 | $-4.36M ▼ | $-3.87M ▼ | $-2K ▼ | $-152K ▲ | $-4.02M ▼ | $-3.87M ▼ |
| Q1-2025 | $-3.99M | $-3.71M | $713K | $-162K | $-3.16M | $-3.71M |
Revenue by Products
| Product | Q4-2021 | Q1-2022 | Q2-2022 | Q3-2022 |
|---|---|---|---|---|
 Ibio Cdmo | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 Ibio Inc | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
CEO
Martin B. Brenner
Compensation Summary
(Year 2025)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2023-11-29 | Reverse | 1:20 |
| 2022-10-10 | Reverse | 1:25 |
ETFs Holding This Stock
Summary
Showing Top 2 of 12
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
LYNX1 CAPITAL MANAGEMENT LP
Shares:1.06M
Value:$2.63M
IKARIAN CAPITAL, LLC
Shares:617.33K
Value:$1.54M
AMERIPRISE FINANCIAL INC
Shares:482.3K
Value:$1.2M
Summary
Showing Top 3 of 39